These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3556196)

  • 1. Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression.
    Schneider-Schaulies J; Schimpl A; Wecker E
    Eur J Immunol; 1987 May; 17(5):713-8. PubMed ID: 3556196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
    Klemsz MJ; Justement LB; Palmer E; Cambier JC
    J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of cellular oncogene expression in mouse lymphocytes. I. Expression of c-myc and c-ras-Ha in T lymphocytes induced by various mitogens.
    Schneider-Schaulies J; Hünig T; Schimpl A; Wecker E
    Eur J Immunol; 1986 Mar; 16(3):312-6. PubMed ID: 3514240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes.
    Wingett D; Reeves R; Magnuson NS
    J Immunol; 1991 Nov; 147(10):3653-9. PubMed ID: 1940364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective T lymphocytes in old mice. Diminished production of mature c-myc RNA after mitogen exposure not attributable to alterations in transcription or RNA stability.
    Buckler AJ; Vie H; Sonenshein GE; Miller RA
    J Immunol; 1988 Apr; 140(7):2442-6. PubMed ID: 3280682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular oncogenes and lymphocyte activation.
    Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
    Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response.
    Rozengurt E; Sinnett-Smith JW
    J Cell Physiol; 1987 May; 131(2):218-25. PubMed ID: 3108267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc and c-fos gene regulation during mouse liver regeneration.
    Sobczak J; Mechti N; Tournier MF; Blanchard JM; Duguet M
    Oncogene; 1989 Dec; 4(12):1503-8. PubMed ID: 2512526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
    Shipp MA; Reinherz EL
    J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of c-fos, c-jun, and c-myc genes is regulated by heat shock in human lymphoid cells.
    Bukh A; Martinez-Valdez H; Freedman SJ; Freedman MH; Cohen A
    J Immunol; 1990 Jun; 144(12):4835-40. PubMed ID: 2112575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
    Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
    Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential protooncogene expression during rat liver regeneration.
    Thompson NL; Mead JE; Braun L; Goyette M; Shank PR; Fausto N
    Cancer Res; 1986 Jun; 46(6):3111-7. PubMed ID: 3516391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
    Futscher BW; Erickson LC
    Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of afterload and angiotensin II on proto-oncogene mRNA levels in the isolated working rat heart.
    Roffe C; MacDiarmaid-Gordon A; Ohanian V; Hollis S; Heagerty AM
    Cardiovasc Res; 1996 Jun; 31(6):907-16. PubMed ID: 8759246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
    Tavassoli M; Shall S
    Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
    Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.
    Nepveu A; Levine RA; Campisi J; Greenberg ME; Ziff EB; Marcu KB
    Oncogene; 1987; 1(3):243-50. PubMed ID: 2455262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional control of c-myc gene expression during stimulation of murine B lymphocytes.
    Buckler AJ; Rothstein TL; Sonenshein GE
    J Immunol; 1990 Jul; 145(2):732-6. PubMed ID: 2195118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple calcium-mediated mechanisms regulate c-myc expression in HL-60 cells.
    Salehi Z; Niedel JE
    J Immunol; 1990 Jul; 145(1):276-82. PubMed ID: 2113555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.